Chen Wenwen, Jian Xingling, Yu Bo
Department of Clinical Medicine, Shandong Second Medical University, Weifang, China.
Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, China.
J Cosmet Dermatol. 2025 Jan;24(1):e16707. doi: 10.1111/jocd.16707.
Melasma, a common skin pigmentation disease, can negatively impact patients' mental health, social interactions, and physical appearance. Although we now have several treatments accessible, such as medicines, chemical peels, and phototherapy, which can help ease symptoms to some extent, the requirement for a long-term effective and safe treatment for patients is far from met. In the face of this problem, microneedling, as an innovative treatment, provides a new avenue for treating melasma. Although microneedling has been extensively investigated for treating other skin issues such as inflammation, scarring, and photoaging, research into its use in melasma treatment is still in its early stages.
This study aimed to gather and assess clinical information on microneedling's effectiveness in treating melasma, covering research gaps and serving as a beneficial reference for clinical therapy.
We searched PubMed, Cochrane, Scopus, Embase, and Web of Science databases for articles with the keywords "microneedling," "percutaneous collagen induction", and "melasma." Following a thorough assessment, we selected 64 clinical studies that matched the requirements for in-depth analysis.
After thoroughly reviewing these data, we concluded that microneedling has tremendous potential for treating melasma. Microneedling can significantly improve treatment outcomes, especially when paired with additional therapies such as topical medicines or phototherapy.
Overall, the evidence reported in this study demonstrates that microneedling is an essential advancement in melasma treatment. Not only can it improve the efficacy of topical drugs and other treatment modalities, but it also has an excellent safety and tolerability profile, making it desirable to patients and clinicians. While the current findings are encouraging, more study is needed to refine treatment protocols, investigate the long-term consequences of microneedling, and establish it as the standard of care for melasma treatment. We anticipate that microneedling will play an increasingly important role in the future of melasma treatment, providing our patients with more hope and a broader choice of treatment alternatives.
黄褐斑是一种常见的皮肤色素沉着疾病,会对患者的心理健康、社交互动和外貌产生负面影响。尽管我们现在有多种治疗方法可供选择,如药物治疗、化学剥脱术和光疗,这些方法可以在一定程度上缓解症状,但患者对长期有效且安全的治疗方法的需求仍远未得到满足。面对这一问题,微针治疗作为一种创新疗法,为黄褐斑的治疗提供了一条新途径。虽然微针治疗在治疗其他皮肤问题如炎症、瘢痕和光老化方面已得到广泛研究,但其在黄褐斑治疗中的应用研究仍处于早期阶段。
本研究旨在收集和评估微针治疗黄褐斑有效性的临床信息,填补研究空白,并为临床治疗提供有益参考。
我们在PubMed、Cochrane、Scopus、Embase和Web of Science数据库中搜索了关键词为“微针治疗”、“经皮胶原诱导”和“黄褐斑”的文章。经过全面评估,我们选择了64项符合深入分析要求的临床研究。
在对这些数据进行全面审查后,我们得出结论,微针治疗在黄褐斑治疗方面具有巨大潜力。微针治疗可以显著改善治疗效果,特别是与外用药物或光疗等其他疗法联合使用时。
总体而言,本研究报告的证据表明微针治疗是黄褐斑治疗的一项重要进展。它不仅可以提高外用药物和其他治疗方式的疗效,还具有出色的安全性和耐受性,受到患者和临床医生的青睐。虽然目前的研究结果令人鼓舞,但仍需要更多研究来完善治疗方案,调查微针治疗的长期后果,并将其确立为黄褐斑治疗的标准治疗方法。我们预计微针治疗在未来的黄褐斑治疗中将发挥越来越重要的作用,为我们的患者提供更多希望和更广泛的治疗选择。